Form 4: Monte Rosa Officer Sells Shares for Tax Obligations

Monte Rosa Therapeutics' Principal Accounting Officer, Edmund Dunn, sold 1,039 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Edmund Dunn, Principal Accounting Officer of Monte Rosa Therapeutics, Inc. (GLUE), reported a transaction on January 5, 2026.
• The transaction involved the sale of 1,039 shares of common stock.
• The shares were sold at a weighted average price of $15.17 per share, with prices ranging from $15.17 to $15.43.
• The sale was non-discretionary and executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Edmund Dunn beneficially owns 22,693 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale to cover tax obligations from RSU vesting, which typically has a neutral impact on market sentiment as it does not reflect management's discretionary view on the company's future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The shares were required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• These sales were automatic and not in the discretion of the Reporting Person.

Industry Context

Insider transactions, particularly those related to tax withholding from equity compensation, are a routine occurrence across all industries for publicly traded companies. This specific transaction is consistent with standard practices for executive compensation and tax management.

Stakeholder Impact

• Shareholders: Minimal direct impact as the sale is non-discretionary and for tax purposes, not indicative of a change in management's confidence.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The reported transaction is a routine, non-discretionary sale by an officer to cover tax withholding obligations associated with restricted stock unit vesting. It does not reflect a discretionary decision by management regarding the company's future prospects or valuation, and therefore, does not provide new information that would warrant a change in investment recommendation based solely on this filing.

Keywords

Monte Rosa Therapeutics, GLUE, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Officer Transaction